Health-Tech & AI · Dubai & the GCC
Health-tech go-to-market that turns product into pipeline.
A working product is not yet a business. The platform runs, the demo lands, and then the questions arrive in the wrong order: who actually pays, which regulator gates a deployment, whose signature makes the second sale easier than the first. A health-tech venture is carried by those answers, not by the software. SULD works with founders in Dubai and across the GCC on what sits between a product and a market — the buyer, the pathway, and the route into the providers, payers and health systems that decide whether anything gets deployed. You built the technology. The business around it is the work.
Where we make the difference.
Who pays, decided first
The buyer, the model and the motion settled before the spend — which provider group, payer or health system the product is sold to, what they are buying, and what has to be true before they can sign.
Regulatory-aware commercialization
We navigate the UAE and GCC digital-health landscape so compliance clears your path to market instead of blocking it.
Distribution and access
We open conversations with the providers, payers, and health systems that founders struggle to reach on their own.
Investor and scale readiness
The evidence your next raise and your regional expansion turn on is produced during the work, not reconstructed the month before an investor asks for it.
A GCC market entry built with SULD DNA — the order, the pace, the finish. Then it is yours.
The order decides what is settled first: where the product creates commercial value, who pays for it, and which regulatory questions gate a deployment — before pilots are signed. The pace runs entity, pathway, pilots and first revenue backwards from the date the business has to be live, so nothing is discovered during a procurement review. The finish is the evidence pack, the contracting and the onboarding held to the standard of the pitch deck. Then it is yours — the metrics, the relationships and a motion your own team repeats from first traction to regional scale.
You get an operating partner invested in your revenue, not a vendor invested in a deliverable.
Business consultancy for health-tech & ai →Built with SULD DNAYour UAE market entry, run as one sequenced program.
For a health-tech venture the thing being launched is a market entry, not a building. The sequence still decides the outcome: entity and regulatory pathway gate the pilots, pilots gate the reference customers, and reference customers are what make the next raise credible. We run that sequence as one program.
- 01
Entity & structure
Free zone or mainland chosen against who you sell to, what you own, and where the business is going — not against whichever package was cheapest.
- 02
Regulatory pathway
The digital-health, telehealth and data-residency requirements that gate a deployment, mapped and evidenced before a pilot is signed rather than discovered during procurement review. Formal legal opinions stay with counsel; we own the readiness file and the sequence.
- 03
Pilots & reference sites
The first provider or payer pilots designed to produce evidence you can sell with, not just a logo for the deck.
- 04
Distribution & first revenue
Warm routes into provider groups, payers and health systems, then the pricing, contracting and onboarding mechanics that turn a first signature into a motion your own team can repeat.
- 05
Traction & scale readiness
The deployment data, unit economics and named reference sites assembled into the evidence pack an investor or a second-market buyer actually asks for.
Health-Tech & AI — questions answered.
We have a product but no GCC traction — where do you start?
With who pays. Not the user, and not the enthusiast who agrees to a pilot — the budget the deployment is bought out of. Name that, and the regulatory pathway, the pilot design and the route in all follow from it. Most of what arrives as a marketing problem turns out to have been an order problem.
Can you navigate digital-health regulation in the UAE and GCC?
Yes — as part of the launch, not a separate exercise bolted on afterwards. Each market's requirements are read early enough to set the order of the work: what has to be true before a pilot, before data crosses a border, before a procurement review starts asking. Formal legal opinions stay with your counsel; the sequence and the evidence behind it are ours.
Are you a development or engineering firm?
No. You build the technology; we build the business around it — strategy, market access, distribution, and pipeline. Where the build ends, that is our starting sign.
Health-Tech & AI — field notes for operators.
Relocating Your Business to the UAE: The Operator's First 90 Days
The move to the UAE fails less at the license than in the ninety days after it — the stretch nobody schedules. Here is the operator's version of that window.
Read the guideMarketing That Drives DemandWhy Your Marketing Generates Leads but No Pipeline (and How to Fix It)
Impressions up, cost per lead down, inbox full — yet qualified pipeline has barely moved. Here's where the value leaks, and the operator-led fix.
Read the guide
